Boston - iLead Feed Boston - All the last new posts on iLead http://ilead.top/index.rss?q=Boston <![CDATA[Video Trends Point to Changing Ways Companies Reach Consumers]]> Boston Xcon Boulder Denver Xcon Detroit Xcon Indiana Indiana Xcon National Xcon New York Xcon Raleigh-Durham Xcon San Diego Xcon San Francisco Xcon Seattle Xcon Texas Xcon Wisconsin Xcon Xcon2017 facebook IT Mobile Realync startups <![CDATA[Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug]]> Pharma Drugs Drug Boston Boston blog main Boston top stories National blog main Raleigh-Durham blog main Aditech Pharma Biogen Biotech FDA Food and Drug Administration Forward Pharma Fumapharm Life Sciences Michael Yee patent RBC Capital Markets U.S. Patent and Trademark Office <![CDATA[Neurala, With More Cash, Advances A.I. for Drones, Self-Driving Cars]]> Computers NASA Boston Boston blog main Boston top stories National blog main National top stories 360 Capital Partners A.I. Anatoly Gorshechnikov Artificial Intelligence autonomous vehicles Boston University BU Computer Vision Consumer Tech deep learning Draper Associates Driverless cars drones Ecomobility Ventures Electranova Capital II Fund GPU Heather Ames Idinvest Partners Massimiliano Versace Max Versace Motorola Solutions Venture Capital nasa Neurala Pelion Venture Partners RoboticsAI Roger Matus Self-Driving Cars Sherpa Capital SK Ventures Software Tech Techstars Boston VC <![CDATA[Boston Cream Pie]]> Recipes French Dessert Pie Cream American Cake Boston Chocolate Cake and Cupcakes Desserts Pies and Crusts Sweet Treats Chocolate- Bittersweet Corn Syrup Egg Yolks Half and Half Cream Heavy Whipping Cream Milk Whole <![CDATA[Elizabeth Warren goes after Trump and team of ‘bigots']]> News Democrats Donald Trump Election Republicans <![CDATA[Warren embraces her role as a top Democratic foil to Trump]]> News Democrats Donald Trump Election Republicans <![CDATA[Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More]]> Industrial Healthcare Biopharma Biotech BioPharma BioTech Boston blog main Boulder Denver blog main Detroit blog main Indiana blog main National National blog main New York blog main Raleigh-Durham blog main San Diego blog main San Francisco blog main Seattle blog main Texas blog main Wisconsin blog main Adynxx Allergan Amgen Anokion ARCH Venture Partners Ariad Pharmaceuticals Assembly Biosciences Biogen CureVac deals Donald Trump Ed Kaye Eteplirsen Exondys 51 FDA gender diversity George Scangos Hill-Rom Holdings J.P. Morgan Healthcare Conference JLabs Johnson & Johnson Len Schleifer Life Sciences Lysosomal Therapeutics Maverick Therapeutics Melinda Richter Merck KGaA Merrimack Pharmaceuticals ModeRNA Therapeutics Mortara Instrument Nationwide Children’s Hospital Nivalis Therapeutics PCSK9 Regeneron Pharmaceuticals Roundups Sarepta Therapeutics Takeda Pharmaceutical Tesaro Vertex Pharmaceuticals Vir Biotechnology <![CDATA[Notes From The JPM '17 Vortex: Trump, Rainstorms & The Price You Pay]]> Healthcare Drugs Drug Boston blog main Boston top stories Boulder Denver blog main Denver top stories Detroit blog main Detroit top stories Indiana blog main Indiana top stories National National blog main National top stories New York blog main New York top stories Raleigh-Durham blog main Raleigh-Durham top stories San Diego blog main San Diego top stories San Francisco blog main San Francisco top stories Seattle blog main Seattle top stories Texas blog main Texas top stories Wisconsin blog main Wisconsin top stories Allergan Alnylam Pharmaceuticals Barry Greene BioMarin Biotech Blindness Brent Saunders Cancer Moonshot Centers for Disease Control clinical trials Conference Donald Trump drisapersen Ed Kaye Eteplirsen Exondys 51 FDA approval Gene Therapy Greg Simon Hank fuchs J.P. Morgan Janet Woodcock Jeff Marrazzo Jeff Mazzarro JJ Bienaime Joe Biden Johnson & Johnson JP Morgan JPM17 JPMorgan Julie Gerberding Life Sciences Maraganore Martin Shkreli Merck Novo Nordisk panel patient patisiran pay performance Poliwogg President elect Pricing rare disease San Francisco Sarepta Therapeutics Spark Therapetuics <![CDATA['Patriots Day': A Painful, Painstaking Depiction Of The Boston Marathon Bombing]]> Stars Mark Wahlberg <![CDATA[Bruins lose Rask in narrow loss to Predators]]> <![CDATA[Bruins goalie Tuukka Rask out of game after puck hit mask]]> Nhl nhl <![CDATA[Concussions could cause Alzheimer's: Researchers find clearest ever link]]> Senior Brain Alzheimer <![CDATA[Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA]]> Manufacturing Cancer Clinical Drug Drugs Boston Boston blog main National blog main Biotech cancer FDA Food and Drug Administration Life Sciences Merck Pozen Regeneron Sanofi Tesaro <![CDATA[Washington Wizards Unable To Keep Up With Boston Celtics On Road]]> Nba nba <![CDATA[Thomas scores 38, Celtics pull away to beat Wizards 117-108]]> Sport <![CDATA[3 Amazing Ways To Honor A Boston Terrier Who Passed Away]]> Breed Dogs Boston Terrier Dog Terrier Pet Loss <![CDATA[Biopharma Leaders Call for Gender Diversity Amid J.P. Morgan Conference]]> Science BioPharma Industrial Healthcare Biopharma Life Sciences Boston blog main Boston top stories Boulder Denver blog main Detroit blog main Indiana blog main National blog main National top stories New York blog main Raleigh-Durham blog main San Diego blog main San Francisco San Francisco blog main San Francisco top stories Seattle blog main Texas blog main Wisconsin blog main BioCentury Biopharma Executive Council Diversity gender diversity gender gap healthcare J.P. Morgan Karen Bernstein Kate Bingham Letter LifeSci Advisors Massachusetts Biotechnology Council MassBio Open Letter people SV Life Sciences women <![CDATA[Vertex Deals Cancer Drugs to Merck for $230M, Staying True to Plan]]> Therapies Research Clinical Cancer Drugs Drug DNA Pharmaceuticals Pharmaceutical Boston Boston blog main Boston top stories National blog main cancer Cancer Drug cancer therapy Cystic Fibrosis David Altshuler Development DNA damage DNA damage and repair Drug Development exome Gilead Sciences Hepatitis C immune-oncology Immuno-oncology Incivek Ivacaftor Jeff Leiden Jefferies Kalydeco Life Science Life Sciences Lungs Merck mucus out-licensing Phase 1 phase 2 protein kinase inhibitor R&D rare disorders research sofosbuvir Sovaldi telaprevir Therapy Vertex Vertex Pharmaceuticals VX-970 <![CDATA[EzCater Gobbles $35M From Iconiq Capital, Insight Venture Partners]]> Food Boston Boston blog main Boston top stories National blog main Apps David Meiselman ezCater food delivery food ordering Iconiq Capital Insight Venture Partners Mobile on demand Software startups Stefania Mallett Tech VC <![CDATA[Edtech Venture Funding Down in 2016, But Still Tops $1B]]> General Industrial Boston blog main Boulder Denver blog main Detroit blog main Detroit top stories Indiana blog main Indiana top stories National National blog main National top stories New York blog main Raleigh-Durham blog main San Diego blog main San Francisco blog main San Francisco top stories Seattle blog main Texas blog main Wisconsin blog main Age of Learning EdSurge EdTech Education Galvanize IT Kaltura Software startups students Teachers Udemy Universities VC Venture Capital